Development of predictive computational models for cancer patient outcomes based on molecular and clinical data. This service enables personalized prognosis and treatment planning.
Manufactured by
China
PreceDo Pharmaceuticals is a state-controlled high-tech enterprise established in 2015, affiliated with Chinese Academy of Sciences Hefei Institute. The company specializes in cell engineering technology, featuring proprietary HDS tumor precision medication technology, Ba/F3 cancer kinase target engineered cell library, and an approved renewable cancer primary cell biobank for anti-tumor drug development and clinical precision treatment.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Hahn-Schickard-Gesellschaft für angewandte Forschung e.V.
Germany · 1 relevant product
ONCOMEDICS SAS
France · 2 relevant products
FYELABS INCORPORATED
Canada · 1 relevant product
24 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 31 closest product alternatives
Hahn-Schickard-Gesellschaft für angewandte Forschung e.V. · Germany
Computational modeling and simulation services for medical device design and optimization. Simulation tools predict device performance and guide development decisions.
ONCOMEDICS SAS · France
Software solution for oncologists to plan and optimize cancer treatment protocols, integrating patient imaging data and treatment algorithms for personalized care management.
FYELABS INCORPORATED · Canada
Digital twin computational modeling platform for medical device development and validation. Enables virtual testing, simulation, and optimization of medical devices and systems to reduce physical prototyping costs and accelerate time-to-market. Supports iterative design refinement across hardware, software, and AI components for regulatory compliance and clinical efficacy.
28 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products